Brief: Eckert & Ziegler To Supply Actinium Pharmaceuticals With AC-225 For Comprehensive Development Activities
March 25 (Reuters) - ECKERT & ZIEGLER SE EUZG.DE: TO SUPPLY ACTINIUM PHARMACEUTICALS WITH AC-225 FOR COMPREHENSIVE DEVELOPMENT ACTIVITIES ACTINIUM PHARMACEUTICALS TO FURTHER DEVELOP ACTIMAB-A AS WELL AS ADDITIONAL EARLY AND LATE-STAGE DEVELOPMENT CANDIDATES FOR BOTH U.S. AND INTERNATIONAL CLINICAL TRIALS Source text: ID:nEQ1YrSlna Further company coverage: EUZG.DE (Gdansk Newsroom) ((Gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Eckert & Ziegler SE
See all newsBrief: Eckert & Ziegler Brazil And Terthera Sign Supply Agreement For Terbium-161
Germany's Eckert & Ziegler H1 net income rises, confirms FY view
Brief: Eckert & Ziegler - FY Outlook Confirmed
Brief: Eckert & Ziegler: BaFin Questions Pentixapharm Spin-Off Accounting at Eckert & Ziegler
Germany's Eckert & Ziegler Q1 sales rise on medical segment growth